MEIP - Chief Medical Officer at MEI Pharma Acquires Company Stock Options Worth 30000 Shares | Benzinga
RICHARD GHALIE, Chief Medical Officer at MEI Pharma (NASDAQ:MEIP), reported a large acquisition of company stock options on October 12, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that GHALIE, Chief Medical Officer at MEI Pharma, a company in the Health Care sector, was just awarded stock options worth 30,000 shares of MEIP. The options give GHALIE the right to buy the company's stock at $7.01 per share.
MEI Pharma shares are trading down 0.44% at $6.76 at the time of this writing on Friday morning. Since the current price is $6.76, this makes GHALIE's 30,000 shares worth $202,800.